SLC1A2 and gastric cancer: CD44-SLC1A2/EAAT2 gene fusions are detected in 1–2 % of gastric cancers involving the glutamate transporter SLC1A2 [85], and cause intracellular accumulation of glutamate, a growth-promoting amino acid associated with oncogenic functions [97, 98].